A study on factors influencing the quality of total mesorectal excision by Robin Prabhu, I
1 
 
 
A STUDY ON FACTORS INFLUENCING THE QUALITY 
OF TOTAL MESORECTAL EXCISION 
 
Dissertation 
Submitted in partial fulfillment of the regulations of 
M.S. DEGREE EXAMINATION 
BRANCH I GENERAL SURGERY 
 
 
Department of General Surgery 
GOVT. STANLEY MEDICAL COLLEGE AND HOSPITAL 
CHENNAI - 600001 
 
 
 
THE TAMILNADU DR.M.G.R MEDICAL UNIVERSITY 
CHENNAI 
 
APRIL 2014  
2 
 
CERTIFICATE 
 
This is to certify that this dissertation titled 
 
 A STUDY ON FACTORS INFLUENCING THE QUALITY 
OF TOTAL MESORECTAL EXCISION 
 
is  the  bonafide  work done by Dr. Robin  Prabhu I. , Post Graduate 
student  (2011 – 2014)  in  the  Department   of   General  Surgery, 
Government Stanley  Medical College and Hospital, Chennai  under  my  
direct  guidance  and  supervision, in  partial fulfillment of  the  
regulations of  The Tamil Nadu Dr. M.G.R  Medical University, Chennai  
for the award of  M.S., Degree (General Surgery) Branch - I, 
Examination  to  be held in April 2014. 
 
 
 
Prof. S. VISWANATHAN, M.S.,                     Prof. K. KAMARAJ,  M.S., 
Professor of Surgery,         Prof and Head of surgery,  
Dept. of General Surgery,                            Dept. of General Surgery,  
Stanley Medical College,    Stanley Medical College, 
Chennai-600001.     Chennai-600001. 
 
 
 
 
 
 
PROF. S. GEETHA LAKSHMI, M.D., PhD, 
The Dean, 
Stanley Medical College, 
Chennai-600001. 
3 
 
DECLARATION 
 
 I, DR. ROBIN PRABHU I. solemnly declare that this 
dissertation titled A STUDY ON FACTORS INFLUENCING THE 
QUALITY OF TOTAL MESORECTAL EXCISION is a bonafide 
work done by me in the Department of General Surgery, Government 
Stanley Medical College and Hospital, Chennai under the guidance and 
supervision of my unit  chief. 
 
Prof. S. VISWANATHAN, M.S., 
         Professor of Surgery 
 
This dissertation is submitted to The Tamilnadu Dr. M.G.R.  
Medical University, Chennai in partial fulfillment of the university 
regulations for the award of M.S., Degree (General Surgery) Branch - I, 
Examination to be held in April 2014. 
 
 
 
Place:  Chennai. 
Date:   December 2013.                           DR. ROBIN PRABHU I. 
 
 
 
 
4 
 
 
 
ACKNOWLEDGEMENT 
 
 I am grateful to Prof. S. Geethalakshmi, Dean, Govt. Stanley 
Medical College for permitting me to conduct the study and use the 
resources of the College. 
 My sincere thanks to Prof. K. Kamaraj, Professor and HOD, 
Department of General Surgery, for his valuable guidance throughout 
the study.  
I am highly indebted to my guide Prof. S. Viswanathan, 
Professor of Surgery for his constant help, inspiration and valuable 
advice in preparing this dissertation. 
I express my deepest sense of thankfulness to my Assistant 
Professors Dr. T. Babu Antony, Dr. C. Manimegalai, Dr. R. 
Abraham Jebakumar for their valuable inputs and constant 
encouragement without which this dissertation could not have been 
completed. 
I consider it a privilege to have done this study under the 
supervision of my beloved former Professor and Head of the Department 
Prof. P. Darwin, who has been a source of constant inspiration and 
encouragement to accomplish this work.  
5 
 
I am particularly thankful to my fellow postgraduate colleagues 
for their valuable support in the time of need throughout this study. 
  It is my earnest duty to thank my parents without whom 
accomplishing this task would have been impossible. 
 I am extremely thankful to my patients who consented and 
participated to make this study possible. 
 
6 
 
 
CONTENTS 
INTRODUCTION        - 1 
AIM OF THE STUDY        - 3 
HISTORY          - 4 
TECHNIQUE OF TME       -14 
REVIEW OF LITERATURE      -36 
PROBLEMS AND CONROVERSIES    -45 
MATERIALS AND METHODS     -63 
OBSERVATIONS AND RESULTS     -67 
CONCLUSIONS AND RECOMMENDATIONS   -80 
BIBLIOGRAPHY        -82 
ANNEXURES        -89 
MASTER CHART        
 
 
A STUDY ON FACTORS INFLUENCING THE QUALITY 
OF TOTAL MESORECTAL EXCISION 
 
 
Abstract 
 
Background: 
Total mesorectal excision (TME) has become the standard of care for rectal cancer. 
Incomplete TME has been found lead to local recurrence. The factors which impact the TME 
have been scarcely studied. In this study we plan to investigate those factors which affect the 
quality of TME.  
 
Methods: 
Data of patients undergoing resectional surgery for adenocarcinoma of the rectum were 
entered into the database. This data included age, sex, BMI, distance of tumor from anal 
verge, pathological tumor stage, use of neo-adjuvant therapy, surgical modality, duration of 
surgery, presence of intra-op complications and type of dissection technique. The specimen 
after surgery was examined both by the surgeon and the pathologist. It was classified either as 
optimal TME or sub-optimal TME. Statistical analysis was done using chi-square test for 
categorical variables and ANOVA for continuous variables.  
 
Results: 
Of a total 50 patient, 38 patients were found to have grade 1 TME, 8 with grade 2 TME and 4 
with grade 3 TME. Significant association (p<0.05) was found between Pathological tumour 
category T4, presence of intra-operative complications, surgery lasting longer than 240 mins 
and use of monopolar or blunt dissection.  No significance was seen with  age of patient, 
gender, BMI of the patient, distance of tumor from anal verge, type of surgical approach or 
neo-adjuvant therapy, 
 
Conclusion: 
Negative impact on TME was found with distinctive disease and surgery related factors.  
Key Words:  
TME, Rectal carcinoma, mesorectum, dissection, Low anterior resection, Abdomino-perineal 
resection, recurrence, quality 
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INTRODUCTION 
Colorectal malignancy is the second leading cause of cancer 
deaths and is one of the challenging problems encountered by surgeons 
today. Globally, nearly 800,000 new cases occur and death is estimated 
at nearly 450,000. Local recurrence after surgery may be largely related 
to technique used and leads to considerable morbidity. Mortality is 
generally related to the systemic spread of disease prior to surgical 
treatment. This problem has received wider attention over the past 
decade. Though earlier reported local recurrence neared 30%, 
2
 recent 
advances have reduced it  to less than 10%. The two major advances in 
this period have been the use of neo-adjuvant therapy and change in 
surgical technique created by a better understanding of the local spread 
of rectal cancers. Modern surgery for rectal malignancy is based on a 
total mesorectal excision (TME) which involves sharp, complete 
extirpation of the cancer en bloc along a thin fascial layer which contains 
the surrounding perirectal lymphatic tissue. The description mesorectum 
refers to a fatty connective tissue layer of lymphatics, lymph nodes and 
associated vessels measuring 2–3 cm in thickness, which surrounds the 
rectum and is enveloped by fascia. Mesorectal excision refers to the 
excision of this soft tissue envelope under direct vision using sharp 
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instruments, dissecting between the visceral and parietal fascia. The 
embryonal plane between the parietal and visceral pelvic fasciae has 
been referred to as the “holy plane”.5 A mesorectal excision can be of 
two types -  total (TME) or partial (PME) depending on the distal extent 
of surgery. It is said to be total if mesorectum is completely excised 
down to the pelvic floor and is indicated for malignancy of the middle 
and lower third of the rectum. Partial Mesorectal Excision  is done for 
treatment of malignancy of the upper one third of the rectum
5
 , although 
circumferentially it is performed in the same way as for Total, distally 
the mesorectum is transected perpendicular to the rectal wall at a 
distance of 5 cm beyond the distal most edge of the tumour;  
Various Clinical studies have shown incomplete total mesorectal 
excision to be associated with increased local and overall recurrences. 
The factors which are significantly associated with incomplete 
mesorectal excision have scarcely been studied. In this regard, it 
becomes necessary to detect preoperative patient-, treatment- and 
disease- related factors that are associated with incomplete mesorectal 
excision. 
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AIMS & OBJECTIVES 
The aim of my study is to 
 Determine the patients undergoing surgery for rectal 
malignancy with adequate total mesorectal excision, and    
 Identify the patient, disease and surgery related factors 
which influenced the quality of mesorectal  excision . 
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HISTORY 
The Romanian anatomist Thoma Jonnesco gave the first available 
description on the mesorectum, though he did not call it by that name. It 
was published in the Traite d'Anatomie Humaine which was authored by 
Poirier and Charpy in 1896. It remained unchanged in the second edition 
of the book. It was also referenced by Gerota
5
 and Waldeyer
6
  in their 
monographs on rectal anatomy. Jonnesco’s observations dictated that the 
rectum was encapsulated within a thin fibrous sheath, which separated it 
from the other pelvic organs, and how the rectum could be mobilized 
easily from the sacrum and presacral vessels by proper respect for this 
fibrous sheath.
3
 
The first to describe the procedure of total mesorectal 
excision
7
 was Abel in 1931.
8
 However, TME was given widespread 
attention by the English Surgeon Heald in 1979
9
. He reported from his 
clinical experience at the North Hampshire Hospital situated in 
Basingstoke, England. In his publication, he ascribed the method of 
TME and postulated the important steps in surgery for rectal 
malignancy. He emphasized on the use of direct vision and sharp 
dissection during the mobilization of the rectum to remain between the 
parietal and visceral pelvic fascia. Contemporary surgeons often have 
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argued, even prior to it being described as total mesorectal excision, that 
this technique was practiced by many others. Heald was still the first 
person to describe the steps of a formal proctectomy for rectal 
malignancy and demonstrated why deviation from this anatomical plane 
is unacceptable in modern surgery. He reported the lowest recurrence 
rates at that time. In his first series of 112 patients
2
  he showed a 5-year 
survival of 87.5% and a 5-year local recurrence rate of 2.7%. Heald's 
extraordinary results were questioned by many at the 
time;
10
 nevertheless, more recent series
11,12
 with similar  patients samples 
have reported similar recurrence rates and lend support to Heald's 
methods. Heald's publications have introduced TME as the surgical 
technique of choice
13
, and have changed how the technique of 
proctectomy for cancer is taught throughout the world. 
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ANATOMY OF RECTUM 
The Latin word ‘rectus’ means straight, and the rectum is found to 
be straight in monkeys, but since the human rectum follows the posterior 
concavity of the sacrum, it is curved. It also shows three lateral curves or 
flexures that are most prominent when the viscus is distended: upper and 
lower curves convex to the right and a middle curve convex to the left, 
hence the middle part appears to bulge to the left. The lowest part which 
is slightly dilated is known as the rectal ampulla. Corresponding to the 
three curves seen externally, internally there are three sickle-shaped 
transverse rectal folds, formerly called rectal valves (of Houston). They 
project into the lumen from the wall on the concave side of these folds. 
They incorporate the circular muscle of the wall and are not confined 
merely to the mucous membrane, as is the case with the circular folds of 
the duodenum and jejunum. The middle fold which is the largest, 
projects into the lumen from the right wall of the rectum just above the 
ampulla, at the level at which the peritoneum is reflected forwards off 
the rectum to form the floor of the rectovesical or rectouterine pouch; it 
is about 8 cm from the anal orifice and is a useful landmark during 
colonoscopy. 
13 
 
The rectum, which is about 12 cm long, continues as  the sigmoid 
colon at the level of the third segment of the sacrum. There is no clear 
transition between the rectum and the sigmoid colon. At this region the 
sigmoid mesocolon ends gradually and the rectum starts, which has no 
mesentery. The taeniae of the sigmoid colon widen to form anterior and 
posterior muscular bands, which meet laterally to give a complete outer 
layer of longitudinal muscle; leading to loss of sacculations. There are 
also no appendices epiploicae in the rectum. 
The rectum proceeds downwards and backwards as the anal canal 
2–3 cm in front of the coccyx. The anorectal junction is slung forwards 
by the loop of the puborectalis, which merges with the top of the 
external anal sphincter, forming a palpable ledge (the anorectal ring) on 
per rectal examination. Hence the posterior wall of the rectum appears to 
make a right-angle at the anorectal junction. This angle widens during 
defecation as the puborectalis muscle sling relaxes to allow faeces to 
enter the anal canal. 
Although the rectum has no mesentery, the connective tissue and 
fat around the rectum is now referred to by surgeons as the mesorectum. 
The visceral fascia surrounding the mesorectum is the mesorectal fascia. 
The mesorectum is bulkier posteriorly, where it also tends to be grooved 
in the midline. It contains the superior rectal artery and its branches, the 
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superior rectal vein and its tributaries, lymphatic vessels and nodes. A 
relatively avascular areolar tissue plane lies in between the mesorectal 
fascia and the parietal pelvic fascia; this forms the plane of surgical 
dissection in total mesorectal excision of the rectum for carcinoma. The 
plane is found to be most evident posteriorly and is only minimal 
laterally where the inferior hypogastric plexus lies tangentially on the 
surface of the mesorectal fascia. Crossing this interface of areolar tissue 
are autonomic nerve fibres from the plexus to the rectum and occasional 
small middle rectal vessels. The ‘lateral ligament’ of the rectum is found 
during surgery by defining surrounding connective tissue from the 
mesorectum; It is not seen on MRI or CT scanning. 
Peritoneum covers the upper third of the rectum at the front and 
laterally, the middle third only at the front; the lower third is free of 
peritoneum which is reflected forwards on to the upper part of the 
bladder (in the male) or upper vagina to form the rectovesical 
pouch or rectouterine pouch (of Douglas). These pouches form the 
lowest parts of the peritoneal cavity. They are 7.5 and 5.5 cm from the 
anal margins in the male and female respectively and within reach of the 
fingertip on rectal examination. They are normally filled by coils of 
small intestine or sigmoid colon. 
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Anterior to the rectovesical pouch is the uppermost part of the 
base of the bladder and the tops of the seminal vesicles. Below the level 
of the pouch are the rest of the bladder base and seminal vesicles, the 
prostate, and the ends of each ureter and vas deferens. Between these 
structures and the rectum, a condensation of fascia forms a rectogenital 
septum—the rectovesical fascia of Denonvilliers. It is connected to the 
floor of the rectovesical pouch above and to the apex of the prostate 
below. In the fetus the rectovesical pouch extends to a lower level than 
in the adult, but gradual fusion of the anterior and posterior walls of the 
pouch accounts for the origin of this septum. The rectovesical fascia of 
Denonvilliers has a distinct whitish appearance, is closer to the rectum 
than to the prostate and is usually removed in rectal excision for 
carcinoma. 
In females, in front of the rectouterine pouch is the uppermost part 
of the vagina (the fornix, with the cervix of the uterus), while below the 
peritoneal reflexion is the rest of the vagina, with the rectogenital septum 
intervening. This thin rectovaginal fascia fuses with the perineal body 
below. 
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Blood supply 
Blood Supply is derived principally from the superior rectal 
artery, with contributions from the middle rectal, inferior rectal and 
median sacral vessels. The inferior mesenteric artery enters the sigmoid 
mesocolon and changes its name to superior rectal on crossing the pelvic 
brim. It crosses the left common iliac vessels medially to the ureter and 
descends in the base of the medial limb of the mesocolon. At the level of 
S3 vertebra (where the rectum begins) it divides into two branches which 
descend on either side of the rectum and subdivide into smaller 
branches. These vessels pierce the rectum and supply the whole 
thickness of the rectal wall. They continue submucosally into the anal 
canal, where they form a porto-systemic anastomosis with branches of 
the inferior rectal artery. The middle rectal arteries are present in only 
one in five people; they are small and supply only the muscle of the mid 
and lower rectum. The inferior rectal arteries are capable of supplying 
the rectum from below to the level of the peritoneal reflection from its 
anterior surface. The median sacral artery makes a small contribution 
posteriorly in the region of the anorectal junction, but its main interest is 
that it may cause bleeding at operations in this region. 
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The veins correspond to the arteries, but anastomose freely with 
one another, forming an internal rectal plexus in the submucosa and 
an external rectal plexus outside the muscular wall. Haemorrhoids are 
formed by the lower end of the internal venous plexus which continues 
with the vascular cushions of the anal canal. The main route of rectal 
venous drainage is via the superior rectal vein to the inferior mesenteric 
vein, which crosses the pelvic brim between the inferior mesenteric 
artery and the ureter. The inferior rectal veins drain to the internal 
pudendal veins. 
Lymph drainage 
Lymphatic drainage from the rectum is mainly upwards. 
Lymphoid follicles in the mucous membrane drain to epicolic nodes on 
the surface of the rectum and to pararectal nodes in the mesorectum. The 
upward drainage is via nodes along the inferior mesenteric artery to 
preaortic nodes. There is minimal lymphatic drainage from the lower 
rectum to internal iliac nodes along middle rectal and inferior rectal 
arteries, and along the median sacral artery to nodes in the hollow of the 
sacrum, and is unlikely to be a route for the metastatic spread of cancer 
if it has not breached the mesorectal fascia. 
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Nerve supply 
The sympathetic supply is derived from fibres that accompany the 
inferior mesenteric and superior rectal arteries from the inferior 
meseneteric plexus. The parasympathetic supply is from S2, 3 and 4 by 
the pelvic splanchnic nerves via the inferior hypogastric plexus; they are 
motor to rectal muscle. The sensation of distension is conveyed by 
parasympathetic afferents. Similar to the bladder, pain fibres appear to 
accompany both sympathetic and parasympathetic fibres. 
Rectal examination 
The structures that can be palpated through the anal canal in both 
sex include the coccyx and sacrum behind, and the ischial spines at the 
sides. The anorectal ring felt posteriorly at the anorectal junction is a 
shelf-like projection over which the tip of the finger can be hooked when 
the patient bears down. In the male the prostate can be felt (but normal 
seminal vesicles are not usually palpable). In the female the cervix can 
be felt through the vaginal wall, with the uterosacral ligaments laterally 
and sometimes the ovaries. 
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Development 
The rectum and the anal canal are derived from the dorsal part of 
the cloaca and the proctodeum. The anal membrane breaks down, at a 
site represented by the pectinate line in the anal canal; the anal valves are 
said to indicate the remains of the membrane. The part of the anal canal 
continuous with the rectum above the pectinate line is endodermal, and 
the part below which is derived from the proctodeum is ectodermal, 
hence the difference in the blood supply, nerve supply and lymph 
drainage of the upper and lower parts of the canal 
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TECHNIQUE 
A therapist in enterostomas should mark the possible sites for 
stoma placement with patient in sitting, standing and supine postures 
before the patient enters the theatre. A Foley catheter is inserted, the 
patient is placed in the required position, namely the modified-lithotomy 
position, and the rectum is irrigated with both a solution with 
tumoricidal action such as povidone iodine and saline. If indicated 
ureteral stents are placed. In the hands of experienced laparoscopic 
surgeons, studies have shown that the surgery can be performed 
laparoscopically as well
31,32
; the same principles adhere whether the 
surgery is minimally invasive or open. 
The intention of the procedure is complete resection of the 
malignancy along with a total pararectal lymph node excision which lies 
within the mesorectum. Additional lymph nodes may be present 
depending on the stage of the tumor, and they should also be dealt with. 
In oncologic proctectomy one overarching principle is that sharp 
dissection must always be performed. Sharp dissection is part of a 
meticulous and exact approach which avoids mesorectal disruption and 
in the process iatrogenic spread of the tumor. It also prevents inadvertent 
injury to the patient by identifying every important adjacent structure. 
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With this approach less blood loss is seen. Distraction bluntly leads to 
haphazard circumferential margins, and imprecise distraction 
compromises the extent of resection. 
To reach the goal of complete resection with adequate radial and 
circumferential margins, the lateral extent of dissection must not breech 
the fascia propria of the rectum. Sharp dissection through Denonvilliers' 
and Waldeyer's fascia is included. To ensure an adequate distal margin, 
the rectum must also be mobilized anteriorly and posteriorly. 
A generous midline incision is made. The peritoneal cavity is 
entered. Presence of secondaries is explored including liver palpation 
bimanually. Then the question of the primary cancer operability in the 
pelvis is also assessed. If there is no evidence of secondaries or an 
unresectable rectal cancer, the surgery is proceeded. Attention is turned 
to the left lateral attachments of the colon. The embryonic plane between 
the colon and retroperitoneum is entered by making an incision along the 
white line of Toldt (lateral peritoneal reflection). There are no blood 
vessels here. Upward traction is given on the left colon, along with 
lateral traction on the retroperitoneal tissues, and plane is developed with 
sharp dissection. The first step is the identification of the left ureter, 
which is swept laterally. The procedure of mobilization is continued 
toward the midline until we have reached the periaortic tissues. Now, we 
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look to mobilize the splenic flexure. The distal half of the transverse 
mesocolon is separated from the omentum by entering the lesser sac. 
The dissection is proceeded down to the base of the mesentery. 
Likewise, the phrenocolic and splenocolic ligaments are divided 
completely by extending the lateral dissection cephalad and around the 
spleen. The left colon now comes to lie in the midline as it is completely 
mobilized. Now, we can identify the origin of the inferior mesenteric 
artery (IMA) from the aorta. Again confirmation of the position of the 
left ureter is done as it is extremely vulnerable here. The IMA is then 
divided and ligated to allow for mobilization of the descending colon. 
Care is taken to preserve the small nerve fibers of the preaortic 
sympathetic/superior hypogastric plexus. This is possible by keeping the 
plane of dissection between the IMA and aorta flush with the posterior 
wall of the artery. At this level the inferior mesenteric vein is also 
divided. Next, the short left colic artery is identified and isolated. It is 
divided and ligated such that the marginal artery communication 
between the ascending and descending branches is still maintained. This 
ensures good collateral blood supply to the anastomosis or to the 
colostomy from the middle colic artery. Dissection is then carried up to 
the edge of the distal descending colon.  Here, the division of marginal 
artery is carried out. Ligation of the artery is done if brisk arterial 
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bleeding is encountered. The descending colon is then divided between 
bowel clamps. When a coloanal anastomosis is planned, as a lengthening 
procedure, the inferior mesenteric vein can be ligated a second time, just 
below the pancreas, preserving the marginal artery.  
The pelvic phase of the operation is then begun with the posterior 
dissection.. The plane immediately posterior to the IMA in the midline is 
developed sharply, which is carried down over the sacral promontory 
and into the pelvis. This must proceed between the presacral fascia and 
the investing fascia of the mesorectum in order to preserve the 
hypogastric nerves. Once they are identified, they have been swept 
laterally out of harm's way. The lateral attachments are divided sharply, 
close to the pelvic sidewall with the tissues held on stretch between the 
blades of a Kelly clamp using electrocautery. Now, the anterior 
dissection is begun. The peritoneal reflection between the lower uterus 
or bladder and the anterior wall of the rectum is incised. For tumors 
located on the anterior wall of the rectum, the peritoneum should be 
incised anterior to the reflection in order to preserve a fascial boundary 
around the tumor.  This will lead into the plane of dissection between 
either the vagina or seminal vesicles/prostate gland and Denonvilliers' 
fascia. It is important to note that the parasympathetic nerves lie anterior 
to the Denonvilliers fascia. Hence there is an increased incidence of 
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injury to the nerves in this region by developing a plane anterior to the 
Denonvilliers fascia. For posterior tumors, nerve injury is minimized by 
developing the plane of dissection posterior to the peritoneal reflection 
between the Denonvilliers fascia and anterior rectal wall. Care is taken 
to mobilize the rectum distal to the tumor. In Low Anterior Resection, 
the rectum is then divided and the creation of anastomosis is done. 
The neurovascular bundles lie anterolateral to Denonvilliers fascia 
and among other structures supply the seminal vesicles. Heald
33
  advised 
a U-shaped incision to be made though Denonvilliers fascia to avoid 
damage to the neurovascular bundles. By avoiding nerve injury, the 
function of the genitalia is preserved. As demonstrated by Lindsey et 
al,
34
 Denonvilliers' fascia lies just anterior to the fascia propria. Between 
the two lies the proper plane of dissection. It is more closely applied to 
the prostate than the rectum. Postoperative sexual dysfunction can be 
minimized by not excising Denonvilliers' fascia but without 
compromising the oncologic outcome of the surgery. 
The necessity of extending the dissection to the levators for 
rectosigmoid and high rectal cancers, have been questioned by some
35
. 
Studies into this have been made by Adrian and Long
35
. They opine that 
wide resection of the affected portion of the mesorectum provides 
comparable oncologic results with adequate distal and radial margins of 
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5 cm and > 1 mm, respectively. Devascularization of the rectum distal to 
the anastomosis may be avoided by not resecting all of the mesorectum. 
A relatively low anastomotic leak rate of 7.3% has been achieved using 
this technique by Adrian and Long
35
 .  
If the case of APR, division of rectum is not necessary distal to the 
cancer.  Instead, a metal ring is used to tag the sigmoid colon and left in 
situ. A Drainage tube is brought out through the lower abdominal wall. 
The dead space of the pelvis is filled up with omentum to exclude the 
small bowel and prevent bowel obstruction post-operatively. The 
abdomen is then closed and the end-descending colostomy matured. 
Now the perineal phase of the surgery begins. A prone jack-knife 
or lithotomy position is employed. Closure of the anus is done with a 
purse-string suture to prevent extrusion of shed tumor cells. A diamond-
shaped skin incision is made around the anus using the midpoint of the 
perineal body, both ischial tuberosities and the tip of the coccyx as 
landmarks. The avascular plane between the sphincters and the perirectal 
fat is followed and the incision is deepened into the ischiorectal fossa. 
Posterior division of the levators is done first under the coccyx and then 
the lateral division is done. The peritoneal cavity is reached and the 
metal ring previously placed in the presacral space is then retrieved. 
Through the posterior perineal wound, the proximal end of the specimen 
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is brought out. In a retrograde fashion and under direct vision the 
anterior dissection is completed. This minimizes the risk of injuring the 
distal ureters, prostate gland, or urethra and provides excellent exposure. 
Risk of violating the tumor is also minimized. Once removal of the 
specimen is done, the deep tissues of the perineal wound are irrigated. It 
is closed with interrupted 0-vicryl figure-of-eight sutures. Finally, 
closure of skin is done with vertical mattress stitches of 3–0 vicryl 
loosely approximated. 
 
VARIATIONS FOR TUMOR LOCATIONS 
For a midrectal cancer the distal resection margin is the distal edge 
of the mesorectum, at least 2 cm below the tumour. 
For a distal rectal cancer the distal resection margin is the bared 
rectal tube 1 cm below the tumour.
12
 
For a distal rectal cancer not invading the sphincters, dissection 
into the intersphincteric plane is sometimes needed to acquire a 1 cm 
distal margin. This dissection extends into the plane of the bared rectal 
tube beneath Waldeyer's fascia and within the upper external anal 
sphincter formed by the puborectalis sling. In females, who have a short 
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anal canal, the anterior circular fibres of the external sphincter may be 
revealed with further dissection in the anterior intersphincteric plane. 
Distal rectal cancer invading the sphincters can be assessed with 
MRI, endorectal ultrasound and clinical examination under anesthesia. 
In such cases, Waldeyer's fascia covering the anorectal junction should 
not be incised to expose the bared distal rectal tube. Instead, an 
abdominoperineal resection is performed by taking a cuff of puborectalis 
and it’s covering endopelvic parietal fascia, resected as the 
circumferential margin of the anorectal junction en bloc with ischiorectal 
fossa fat, external sphincters and perianal skin (TME plus APR). On 
occasion when there is minimal invasion of the puborectalis, a clear 
distal margin can be taken by resecting the puborectalis while sparing 
the distal half of the anal canal and the external anal sphincter. 
An anterior tumour location is worrying for at least three reasons, 
first because of the adjacency of the anterior viscera and thinness of the 
anterior mesorectum. Clinical examination under anesthesia, endorectal 
ultrasound and MRI are useful to determine whether there is an anterior 
fat plane that will permit an anterior resection margin thick enough to 
test negative. If tumour invades the anterior viscera, en bloc resection is 
required for curative resection: TME plus en bloc partial or complete 
resection of anterior viscera such as posterior wall of the vagina or 
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possibly pelvic exenteration for en bloc resection of rectal cancer 
invading the bladder, seminal vesicle and prostate. 
A second concern with anterior location of a tumour is an 
increased risk of “fracturing” of the tumour during dissection. Particular 
care is needed to avoid tearing and fracturing of the anterior mesorectal 
fascia for an anteriorly located tumour. 
A third worry is that the terminal genitourinary parasympathetic 
and sympathetic nerve branches residing in the prostate can be injured 
during dissection of the anterior mesorectum, particularly if the posterior 
prostatic capsule is breached (especially at the posterolateral capsule). 
Consideration should be given to spillage of tumour cells during a 
distal resection. Many clinical and experimental reports show that viable 
tumour cells can be found in the lumen of the rectum and anal canal 
distal to the tumour. To minimize the potential for implantation of these 
intraluminal cancer cells that could potentially cause recurrent cancer, 
Moran and colleagues
13
 have advocated the placement of 2 sequential 
clamps or staple lines with interval intraluminal washout using a 
tumouricidal solution. The first clamp or staple line is placed distal to the 
tumour. The anorectum is irrigated with a tumouricidal or antiseptic 
solution such as water, betadine or chlorhexidine. After the intraluminal 
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washout, the second clamp or staple line is then placed on the true distal 
resection margin, thus avoiding implantation of intraluminal cancer 
cells. 
 
 
SPHINCTER PRESERVATION OR ABDOMINOPERINEAL 
RESECTION? 
The purpose of any oncologic Surgery remains survival and 
prevention of recurrence. But the outcome is not influenced by surgical 
technique alone, but by various other predetermined factors such as 
cancer’s stage and biological behaviour of the tumor. Through proper 
surgical technique and selection of appropriate surgery, minimal local 
recurrence is possible. If it is possible to provide adequate margin, then 
the surgeon can next consider the possibility of a sphincter preserving 
resection. Though much debate exists as to for which patients sphincter 
preservation can be done, there is clear consensus as to the contra-
indications to sphincter preservation. First, it should be determined if the 
tumor involves the anal sphincter. No Attempt at sphincter preservation 
is attempted if the tumor involves the anal sphincter. Next, the function 
of the anal sphincter is assessed. An anastomosis with an incontinent 
anal sphincter would be less functional than a Colostomy. Finally, in 
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very obese patients in whom the safe creation of an anastomosis cannot 
be guaranteed, sphincter preservation is not undertaken.  
Preoperative evaluation of the patient is done, which includes a 
thorough history, physical examination with particular emphasis on 
anorectal examination which includes a digital rectal examination and 
rigid Proctoscopy. The precise distance of the tumor from the anal verge 
can be measured with rigid Proctoscopy. TransRectal Ultrasound is next 
done to further delineate the size of the malignancy, depth of invasion, 
nodal status and infiltration of surrounding structures. It has an accuracy 
of 80 to 95% in assessing the T stage compared to CT with 60 to 75% or 
MRI 75 to 85%. Hence TRUS is preferred. A coloanal anatomosis is 
considered only if there is separation between the cancer and the 
sphincter. If the tumor is fixed to the pelvic floor, or the tumor involves 
the sphincter, an APR is undertaken. TRUS also provides 70 to 75% 
accuracy in determining presence of lymphadenopathy but is inaccurate 
in revealing the architecture of the lymph nodes.  Involvement of vagina 
in women and prostate or seminal vesicles in men is not an absolute 
contra-indication to restorative surgery, but excision of tumor with clear 
margins is essential.  
Sphincter-preserving surgery is still not accepted as a valid 
treatment modality for rectal cancer due to the consideration that APR 
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offers the maximum radial and distal margins. The correlation of tumor 
free margin has been studied and documented by the 
Radiotherapy+TME trial in the Netherlands. They included 656 patients 
in their study and found >2mm margins conferred a local recurrence risk 
of 5.8% while radial margins <2 mm were associated with local 
recurrence of 16%. Distant metastasis was 12.7% with margins >1mm 
and 36.7% for margins < 1mm which was associated with shorter 
survival. The optimum distal margin has been studied by Paty et al
20
 and 
Vernava and Moran,
21
  after the popularization of TME, who have 
conclusively proven that a 2 cm margin is not an accurate delineation for 
optimal surgery. Indeed, many studies have shown that distal infiltration 
of cells is rarely greater than 1 cm.,
22,23,24
 but distal margins ≤ 8 mm have 
shown increased anastomotic recurrence and reduced survival. Hence, if 
tumor free margin of 1 cm cannot be given from the sphincter, then to 
avoid leaving any residual disease behind, an APR must be done. 
Patients with incontinence should have an abdominoperineal 
resection (APR). They will be better adjusted to management of the 
Colostomy than with incontinence caused by anastomosis distally. 
Patients often have incorrect preconceived notions about stomal 
limitations, which can be alleviated by speaking with an enterostomal 
therapist. This also improves patient's expectation of surgery 
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postoperatively.
25
  If a coloanal anastomosis has been performed, bowel 
function will be altered for many months. Increased frequency and loose 
stools are seen more than 5 times a day. This can further worsen over 
time and with post-operative radiotherapy. In some cases, this can be 
partially mitigated by performing a coloplasty or a pouch. Also required 
is a dietary change with increased fiber.  A supporting role is offered by 
anti-motility drugs. It is important to educate the patient on the surgery 
and the patient to have realistic expectations about it. 
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ASSESSMENT OF TME SPECIMEN 
TME is said to be ‘Complete’ if the Mesorectum is intact and 
smooth, defects are not deeper than 5 mm , there is no coning, and the 
CRM is smooth and regular. It is said to be ‘Nearly Complete’ it 
mesorectum is of moderate bulk and irregular, defects extended more 
than 5 mm but the muscularis propria is’t seen, coning is moderate and 
CRM is irregular. Finally, it is said to be ‘Incomplete’ if mesorectum 
shows little bulk, defects are extending beyond muscularis propria, 
marked coning is seen and CRM irregularity is present. 
In general, markers of successful surgery are if surface is smooth 
and without tearing or incisions. If Partial Mesorectal Excision is done, 
the transection plane should be perpendicular to the rectal wall, and 
coning must not occur. Coning is a phenomenon which happens during 
LAR and APR. The surgeon tends to cut towards the tubular rectum 
while dissecting distally, rather than staying outside the facial plane of 
the rectum, namely the visceral mesorectal fascia. A tapered, conical 
appearance is given to the specimen due to this. It is thus a marker of 
suboptimal quality of the surgery.
5
 
The circumferential radial margin (CRM) is another term that is 
applicable for rectal tumours. In the rectum, a bare non‐peritonealised 
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area is located both anteriorly and posteriorly, though not symmetrically. 
The anterior CRM is located below the lowest point of rectal serosa only 
in the most distal aspect of the specimen. The triangularly shaped 
posterior CRM runs throughout up to the start of the sigmoid mesocolon. 
Definition of a positive Circumferential Radial Margin is a direct tumour 
extension (which can be either continuous or discontinuous) or a lymph 
node positive within 1 mm of the non‐peritonealised, radial soft tissue 
edge.
6
 
British guidelines for the examination of resection specimens of 
rectal malignanacy include the presence or absence of perforation, 
degree of coning in distal portions, surgical defects and the assessment 
of contour for bulk. The Royal College of Pathologists, United Kingdom 
recommend leaving, the bowel intact during fixation. This is done so that 
the fixed specimen can be serially sliced and the CRM can be preserved. 
If the specimen is opened, their assessment would be compromised.
7
 
The Working Group of German Cancer Centres and the German 
Cancer Society require an initial assessment done macroscopically. This 
involves documentation of the extent of mesorectal excision (ie TME vs 
PME), of the quality of mesorectal excision as well as coning and 
specimen surface quality, and in the event of PME, distance between 
distal transection and distal tumour edge; these features are classified as 
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smooth and intact or,  local well defined defect ( less than 5 mm vs 
greater than 5 mm), or marked extensive defect (visible muscularis 
propria layer), or tearing/ incision of tumour.  Another recently described 
method is stain marking which is done to detect small tears in the 
mesorectum. Ink or methylene blue solution is injected into the specimen 
postoperatively via the superior rectal artery or IMA. While with optimal 
TME, no leakage is seen; defects in the mesorectal fascia show 
leakages.
9
 
Circumferential radial margin (CRM) 
In patients with rectal malignancy, in terms of predicting the risk 
of local recurrence, the single most important factor is accurate 
determination of CRM. The term positive margin is given for both direct 
extension of the tumour and the positive lymph nodes present within 1 
mm of the CRM. However, certain studies have shown that all positive 
CRMs do not uniformly impact the risk of recurrence in the same way. 
This was demonstrated by Nagtegaal et al. He showed that when a 
positive CR Margin was due to direct tumour extension, they developed 
more frequent local recurrence (22.1% vs 12.4%, p = 0.06) than those 
with a positive CR Margin was due to positive nodes; Their study went 
on to state that in fact, no difference existed in local recurrence rate 
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between patients with a negative CRM and those with positive nodes- 
positive CR Margin.
16
 
  It also appears that a relationship existed between the quality of 
the mesorectum and the risk of having a positive CR Margin. Patients 
with a tumour extension - positive CRM had a more frequent incidence 
of an incomplete mesorectal excision compared to those who had a  CR 
Margin negative (44% versus 24%, at p<0.05). So patients with direct 
tumor extension were more likely to have incomplete excision of the 
mesorectum; interestingly, such a difference was not observed in the 
quality of the mesorectum among patients with a positive nodes - 
positive CRM
16
. 
Thus, a positive radial margin is a margin of less than or equal to 
1mm. Most studies have conclusively shown that increased risk of local 
recurrence exists with tumours within 1 mm of the CR Margin. Wibe et 
al,  using Norwegian Cancer Registry (n = 686) data showed that patients 
with a less than 1 mm margin had a 22% local recurrence rate. This was 
in comparison to patients with a negative CR Margin who had a 5% 
local recurrence rate.
18
 Additionally, increased risk of distant metastases 
was seen with less than 1 mm radial margins (37% versus 15% radial 
margins >1 mm patients) and shorter duration of long term survival 
(70% versus 90% at 2 years for patients with radial margins greater than 
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1 mm).
8
 However, Nagtegaal et al have extended this margin to 2mm 
and shown that patients with a margin less than or equal to 2mm had a 
16% risk of local recurrence while those with a margin greater than 2 
mm had a 6% risk of local recurrence. 
6
 
Important prognostic implications are also due to the location of 
tumour within the mesorectum, since the amount of soft tissue between 
the CRM and the tubular rectum varies circumferentially. To determine 
if tumour location was related to outcome, 401 patients with rectal 
cancer were retrospectively analysed by Lee et al who underwent TME 
procedures. Only males were included in the study as for females, 
complete pelvic exenterations was done in greater frequency. They 
found an increased rate of local recurrence and death in stage matched 
males, with anterior tumours.
19
 This result is mostly due to the region 
between the CRM and the anterior rectal wall have relatively lesser 
amount of soft tissue. 
Also, it was discovered that the risk of local recurrence increases, 
the lower the cancer is in the rectum. It is not known as to whether this is 
due to tumour biology of low rectal cancers or due to the greater 
frequency of APRs performed in such patients. Quirke and other Dutch 
TME study investigators have shown that APR with TME is more often 
associated with poorer prognosis, due to an increased frequency of CRM 
38 
 
involvement and a poorer quality of mesorectum, compared to LAR + 
TME procedures.
20
 This was contradicted in a study by Faerden et al. He 
studied 140 patients prospectively. They had rectal cancer and 
underwent TME.  A higher rate of local recurrence was seen in patients 
with tumours less than 6 cm from the anal verge compared to those 
where the distance was more than 6 cm (18% versus 5%, where p =
0.0014); however, with respect to abdominoperineal resection, no 
difference in the frequency was seen between these groups.
4
 As such 
many factors may influence the low rectal cancers having aggressive 
behaviour, but regardless of the surgical technique, the thin envelope of 
the lowermost portion of the rectum and low volume of distal mesorectal 
soft tissue are contributory factors. 
Lymph nodes 
Overall survival is influenced by systemic spread than by local 
recurrence. Therefore, the single most important determinant becomes 
Lymph node status in terms of overall survival. The five‐year survival 
with positive nodes is 40% which is significantly lower than those with 
negative nodes (68%).
8
 Many studies have not compared both TME and 
lymph node status consistently, thus with some claiming that lymph 
node positivity has a similar impact to local recurrence as CRM 
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positivity. The Heald led Colorectal Research Unit from Basingstoke, 
UK in order to combat such claims, recently published data from 170 
patients who underwent TM Excision for rectal malignancy.
3
 As 
expected patients with positive lymph nodes had a higher local 
recurrence rate compared to negative node patients, but the recurrence in 
positive node patients was only 7.5%; Thus with adequate excision of 
the mesorectum a remarkably low recurrence rate can be attained even 
for node positive rectal cancer. 
How many nodes should by examined to classify a patient as N0. 
The current TNM guidelines declare that a minimum of 12 nodes should 
be examined but these are based on studies that did not consistently 
employ TME.
26
  A possible ideal number of nodes was suggested in a 
study by Wang et al . They microscopically examined whole‐mount 
sections of 5mm serially sliced mesorectums.
17
 In their study, 18 
specimens were examined with 992 lymph nodes, on average 32 per 
rectum and metastases was contained in 148 (15%) of these. 
Interestingly, a majority of the total number ( 922 /93%) and a majority 
of the positive lymph nodes(104 70%) were less than 5 mm in diameter. 
As demonstrated in recent results of the Dutch TME trial, even 12 nodes  
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retrieval is difficult to achieve in practice. Less than 12 nodes were 
available for examination in 82% of node negative patients.
27
 But, the 
surgeon must be encouraged to find more nodes as several studies 
support the fact that this will improve the staging. Two studies were 
done by Caplin et al and Tepper et al in this regard. The first study 
showed that node positive patients had a similar prognosis as node 
negative patients with less than 7 nodes examined. The second study 
showed that patients with greater than 14 nodes harvested had a better 
disease free survival than patients with less than 8 nodes harvested
28,29
 . 
Plus if the minimum number of nodes to be harvested is set as 12, then it 
will lead to under‐staging as after finding twelve nodes, the procedure 
will be abandoned. Also, the more distant nodes may be harvested, 
losing the closer to rectal wall and more proximal nodes. 
The most important factors in determining the harvested number 
of nodes are enthusiasm of the examiner, extent of examination, routine 
visual inspection, palpation and dissection. Adjuncts helpful to 
identification of lymph nodes are fat stretching, xylene clearance, 
ether‐based methods, and wintergreen oil/cedar oil clearance.30,31,32,33,34  
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In fact, the Cancer Committee of the College of American 
Pathologists advised the use of “visual enhancement techniques”  if with 
traditional methods, less than 12 nodes are found.
10
 Special equipment is 
needed for most of the above‐mentioned methods, the use of volatile, 
noxious compounds or upto 3 weeks treatment of pericolic fat. Another 
technique was the usage of  GEWF solution which was successfully used 
by Newell et al. It is a non‐noxious solution, which within 24 hours 
gives good yield of lymph nodes.
35
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REVIEW OF LITERATURE 
Heald and colleagues
36
 conducted the first large case series at 
North Hamphsire Hospital in Basingstoke, England, reviewing their 
experience with TME. It consisted of 519 patients over a 20 year period 
from 1978 to 1997. All patients had adenocarcinoma of the rectum 
proven histologically. The tumors were located up to a distance of 15 cm 
from the anal verge. Dr. Heald standardized the surgical approach by 
performing all the surgeries himself. All surgeries were taken into 
consideration, that is both the surgeries with palliative and curative 
intent. Forty-nine of the 519 patients received preoperative radiation 
therapy. The performed surgeries were Low Anterior Resection- 465, 
Abdomino-perineal Resection-37, Hartman procedures - 10, local 
excisions -4, and laparotomy and closure in 3 surgeries as it was 
discovered to have unresectable disease. The stage wise distribution was: 
Dukes A – 102 patients, Dukes B -167 patients, Dukes C - 142 patients, 
and Dukes D -108 patients indicating metastatic disease or residual 
disease. 382 patients received a diverting stoma and within 2 months, 
they were closed. To record the information, a database was created. 
Follow-up was lost on 1 patient. All other patients were regular in their 
follow-up in their postoperative period.  
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Following LAR, the 10-year survival rate was 80% and the5-year 
survival rate was 81%. Here, local recurrence rates were not affected by 
the location of the anastomosis, location of the tumor, anastomotic leak 
rates, tumor grade or Dukes stage, but by extramural vascular invasion. 
Coming to survival, it was 66% at 10 years and 68% at 5 years. 
But in those treated with aggressive surgery, the survival was 78% at 10 
years and 80% at 5-years. Coming to local recurrence rates, at 10 years it 
was 8% and at 5 years it was 6%. With LAR, the local recurrence was 
5% at 5 and 10 years. In comparison, in the APR patients local 
recurrence was seen at 36% at 10 yrs and 17% at 5 yrs (p value< 0.001). 
Among the patients with distant metastases, none were surviving beyond 
5 years. In LAR, the leak rate was 6.5% which was clinically apparent, 
but another 5.5% of patients had silent but radiologically detected leaks.  
Only in a small percentage of their patients, adjuvant therapy was 
used and therefore could not be included in analysis. Although more 
trials involving impact of adjuvant therapy and TME are now available, 
Heald concluded that that with a properly performed TME, chemo-
radiotherapy might not be necessary. But, those patients undergoing 
APR had uninspiring cure rates. Patients undergoing anterior resection 
were the only ones whose outcomes were improved by TME. It was 
suggested during the perineal portion of the surgery, tumor could have 
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implanted. Also, the low rectal cancers have a thin fascial envelope 
which in some is absent for 1-2 cm, hence, the cancer can infiltrate faster 
into surrounding structures. 
 The Hong Kong Queen Mary published 622 patients who were 
operated with LAR. Those with lower two-thirds rectal malignancy were 
treated with TME; upper rectal and rectosigmoid malignancies were 
treated with a partial mesorectal excision or a cancer-specific PME, 
where the transaction of the rectum was done about 4 to 5 cm below the 
tumor. Eight cm from the anal verge was the median level of the cancer 
in this series. 90.5% of patients received surgery with curative intent 
(positive margins was seen in 3 patients), with palliative procedure being 
done in the rest. 83.1% of patients had a stapled anastomosis. The rest 
had a hand-sewn anastomosis, 73 were high colorectal anastomoses and 
32 were coloanal. 42 patients received radiation therapy, and neo-
adjuvant radiotherapy was given to half of them. 0.8% belonged to stage 
0 , 16.1% to stage I , 36.7% to stage II, 38.4% belonged to stage III, and 
8.5% to stage IV .  
Partial Mesorectal Excision was done in 226 patients and TME 
was performed in 396 patients. The problems with TM Excision were 
higher blood loss, higher incidence of stoma formation, longer operative 
times and longer hospital stays. TME was also associated with a higher 
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rate of anastomotic leaks (8.1%) when compared with PME (1.3%). 
Furthermore, independent risk factors for anastomotic leaks as found by 
multivariate analysis were TME, blood loss > 500 mL, the absence of a 
stoma and male gender. Yet, between patients undergoing TME or PME, 
no significant difference was seen in the overall postoperative mortality 
(1.8%) and morbidity. Univariate analysis showed significant factors 
predicting local recurrence were creation of a coloanal anastomosis, 
stage of disease, perineural or lymphovascular invasion and a distal 
margin of  less than 2 cm. However, multivariate analysis showed high 
rates of local recurrence to be associated with only the presence of a 
coloanal anastomosis and the stage of disease. Actuarial 5-year and 2-
year distant and local recurrence rates were 9.7% and 6.0%. 
39.6 months was the median follow-up for the patients. In all 
patients studied, 74.5% was the 5-year cancer specific survival. Tumor 
stage and the presence or absence of perineural invasion and 
lymphovascular invasion were shown by multivariate analysis to predict 
disease-specific survival. The authors, based on their findings advised 
the use of TME only in limited cases due to higher incidence of stoma 
formation, a more technically demanding surgery, higher anastomotic 
leak rates, and longer operative times. By demonstrating similar cancer-
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specific survival patterns between TME and PME, they have argued that 
oncologic outcome is not altered with this approach. 
Such superior local control has been produced with TM Excision 
that some have questioned the need for neo-adjuvant therapy for 
prevention of local recurrence. The Dutch Colorectal Cancer Group 
investigated the efficacy of TME for rectal cancer with preoperative 
radiotherapy in a landmark study
38
 . Patients without evidence of distant 
metastases and with histologically confirmed adenocarcinoma within 15 
cm of the anal verge were enrolled over the 3-year period. Exclusion 
criteria were patients initially treated with local excision and patients 
with fixed tumors, as were patients with coexisting or previous cancers. 
Additionally, patients who had undergone prior pelvic chemotherapy, or 
radiotherapy or prior large bowel surgery, were also excluded. 
Randomization was done and patients were assigned to TME alone or 
preoperative radiotherapy and TME. Radiotherapy was given for 5 days, 
daily for 5 Gy followed by TME. Follow-up was done every 3 monthly 
in the first year and then once yearly for 2 years. Surveillance involved 
imaging of the liver with CT and endoscopic investigation. Of the 1861 
patients who were included, 937 fell in the surgery alone group and 924 
patients were assigned to the pre-operative radiotherapy and surgery 
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group. There were similar numbers of LARs, APRs and Hartman 
procedures between the two arms of the study. 
The average period between randomization and surgery was 14 
days in the surgery alone group and 21 days in the radiation group, the 
extra days accounting for the days spent on radiotherapy. The surgery 
alone group had a statistically significant (p< 0.001) lesser amount of 
blood loss (900 mL) compared to the radiation group (1000 mL). 
Perineal complications were also increased with radiation therapy 
compared with the surgery alone group (26 vs 18%, p=0.05). 87 patients 
developed local recurrence, of whom 32% had both local and distant 
disease and 52% had an isolated local recurrence. 16% had distant 
metastasis followed by local failure. The local recurrence rate was 8.2% 
in the surgery alone group and 2.4% in the radiation group (p< 0.001). 
Multivariate regression analysis was done, independent risk factors for 
local recurrence were TNM staging (p< 0.001), tumor location (p =
0.03), and treatment group assignment (p<0.001), but surgical 
procedure (p= 0.90) was not found to be statistically significant. 
Additionally, univariate analysis showed that the use of preoperative 
radiotherapy did not reduce the risk of local recurrence for cancers at 
other locations but it did reduce the risk in patients whose tumor was 
within 5 cm from the anal verge. Overall the surgery alone group had a 
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recurrence rate at the time of 2-year follow-up of 20.9% and the 
radiation arm had a recurrence rate of 16.1%. Stage II and III cancers 
had their recurrence rates reduced with preoperative radiotherapy, but 
stage I and IV cancers were not found to be influenced by it.  
Multivariate subgroup analysis showed no interdependence between 
treatment assignment or TNM staging or tumor location. Overall 
survival was the same in both groups, 81.8% in the surgery alone group 
and 82% in the radiation group (p= 0.84). The rate of distant disease was 
significantly different,   16.8% in the surgery alone group and 14.8% in 
the radiation group. At the end of the study period, the patients dead 
were 20%, 231 were cancer-related, 61 were postoperatively and 70 
were deemed due to other causes. The findings of the Dutch study were 
that use of  combination of preoperative radiotherapy and TME 
benefited local control of disease, but did not affect overall survival even 
though distant disease was found to be more common in the surgery 
alone group. The only disadvantage of radiotherapy was the higher intra-
operative blood loss, but morbidity and mortality were not significantly 
increased in comparison with patients not receiving radiotherapy. 
The efficacy between postoperative radiotherapy and neoadjuvant 
radiochemotherapy (RCT) was compared in a German trial 
CAO/ARO/AIO-94
39
 . Here, all patients had locally advanced (T3/T4 or 
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node positive) disease and underwent TM Excision. Randomization of 
all the patients was done to pre- or postoperative RCT. The tumor and 
pelvic nodes were treated with a total dose of 50.4 Gy of radiation. Also, 
5-Fluoro Uracil, as a 120-hour continuous infusion was given with 
radiotherapy at 1000 mg/m
2
/d during the 1
st
 and 5
th
 weeks. In bolus form 
another 4 other cycles of 5-FU were given. In the postoperative 
radiotherapy group, a boost of 5.4 Gy of radiation was also given. In the 
preoperative RCT arm, 4 to 6 weeks after completion of preoperative 
RCT, patient underwent surgery, with 4 cycles of 5-FU given 3 to 4 
weeks post surgery. Immediate surgery was done in the postoperative 
group with 5-fluoro uracil infusion comprising six cycles and started 
within 4 weeks.  
From 26 different hospitals, 805 five patients were randomized. 
The adjuvant group had 363 patients and the neoadjuvant group had 355 
patients. The most common side-effects were diarrhea, with 11% in the 
adjuvant group having grade 3 toxicity and 12% in the neoadjuvant 
group. Grade 3 erythema, nausea, or leukopenia was experienced by less 
than 3% of patients in either arm. Both groups had similar postoperative 
complication rates and no difference was seen in postoperative bleeding 
(3%) or anastomotic leaks (12%). Postoperative mortality between the 
two groups was also not found to be significantly different. 
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In a nutshell, several large prospective studies have shown that 
local recurrence is superiorly controlled with TME than with 
conventional surgical techniques. On the other hand, morbidity is also 
not significantly higher with TME over conventional surgery. With 
regard to neoadjuvant radiotherapy, TME appears to be additive to it, 
and has not been shown to be able to replace it completely from the 
present studies. 
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PROBLEMS AND CONROVERSIES 
The disadvantages of TME appear to be threefold. They include a 
difficult distal pelvic dissection because of the attention required to 
preserve the pelvic autonomic nerves and to maintain an intact 
mesorectal fascial envelope. Dissection of the mid- and distal rectum 
distal to the cul-de-sac is technically more difficult because of the 
decreasing dimensions of the distal pelvis and access impedance by the 
anterior pelvic viscera. Rectal cancers within 10 cm of the anus have 
higher local recurrence rates associated with the increased rate of 
incomplete TME-resected specimens.
9,21
  
Because the mesorectal excision is so complete and leaves a 
“bared” rectal tube distal to the distal edge of the mesorectum, a second 
difficulty is a difficult low colorectal or coloanal anastomosis. This low 
anastomosis has a leak rate of about 15%– 20%, which is substantially 
higher than the 5%–10% leak rate for intraperitoneal colorectal 
anastomoses.
16,17
  
It is therefore prudent to construct a temporary defunctioning 
ileostomy or right transverse colostomy to protect the patient from 
severe sepsis in the event of anastomotic leakage. Once the low 
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anastomosis is proven to have healed, a subsequent surgery to close the 
defunctioning stoma will be required. 
Despite the preservation of the anal sphincter, a third disadvantage 
is the loss of rectal reservoir function, resulting in increased frequency 
and urgency and decreased ability to delay defecation, with possible 
fecal incontinence. Injury to the anal sphincter from radiation therapy 
will worsen problems of incontinence. 
Whether TME is needed for upper rectal cancer is controversial. 
TME removes all pararectal lymph nodes within the mesorectum, 
including lymph nodes distal to the cancer. Pathological examination of 
mesorectal specimens of upper rectal cancer have not shown metastases 
to lymph nodes in the mesorectum more than 5 cm distal to the 
cancer.
18,19,20
  
Therefore a subtotal mesorectal excision with a distal 5-cm margin 
is likely sufficient to remove all pararectal lymph nodes with potential to 
contain metastases. In performing a subtotal mesorectal excision it is 
imperative to resect the distal mesorectal margin at right angles to the 
long axis of the rectum, so as not to leave behind lymph nodes with 
malignant potential; in other words, do not “cone” into the distal 
mesorectal resection margin. 
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Dissection distal to the cul-de-sac takes extra time and care. Although 
some surgeons dissect anteriorly early in the dissection of the 
midmesorectum, early posterior dissection to the pelvic floor greatly 
facilitates identification of the lateral stalks.  
In some cases where dissection of the mid- and distal mesorectum 
is made more difficult by increased adherence (e.g., in cases of 
inflammation or fibrosis), moving the dissection from the right side to 
the left and vice versa may facilitate the dissection. If the progress of 
dissection is particularly slow at any point, sometimes leaving that area 
and dissecting in another area such as the contralateral side of the 
mesorectum will permit improved distraction of tissue planes upon 
return to dissection of the original area of non-progress. 
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IMPACT OF TME AND PROBLEMS WITH ANASTOMOTIC 
LEAKS 
 
The Dutch Colorectal Group which was conducted in The 
Netherlands, did a  comparative study
40
  on outcomes from the Total 
Mesorectal Excision and rectal cancer trial conducted by them
38
with data 
from another trial, the older cancer recurrence and blood transfusion 
(CRAB)  trial. In the CRAB trial, conducted before TME, much 
emphasis on standard surgical principles was not made. In both studies, 
surgery was the primary treatment modality and neoadjuvant 
radiotherapy had not been used. But, the two studies were not truly 
comparable. This study had more older female patients, and more cases 
of postoperative radiotherapy. But, they did not differ in terms of tumor 
stage, procedures done and tumor location. Higher incidence of 
anastomotic leaks in the TME group was shown by Univariate analysis, 
but on multi-variate analysis, a statistically significant difference was not 
seen. However, in the TME trial, local recurrence was improved (9 
versus 16%). Also, whether the patient underwent conventional surgery 
or TME had a bearing on overall survival with (p= 0.019) a higher 
survival rate in the TME trial. 
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Law
41
  reviewed 205 patients and reported similar findings in 
rectal cancer resections that were less than six cm from the anal verge. 
During the period of patient accrual, a reduction in the incidence of 
APRs was observed by the authors from 36 to 20%. In contrast, the APR 
group showed more five-year actuarial local recurrence (23.5%) than the 
group with double-stapled anastomoses (11.2%). Overall, the 5-year 
survival rate was 51.1% in the APR group while in the LAR group was 
69.1%. But significance was not found. Anastomotic leak was 
experienced by only 6 patients. 
Higher leak rates
42
  with TME have been reported by some series, 
raising concerns that higher leak rates were the price of the improved 
oncologic results. Several explanations have been posed as to why this 
complication is more likely with TME. Difficulty was experienced in 
report reading as all the studies did not follow a common protocol. They 
differed in terms of leak definition, usage of  pelvic DTs,  anastomotic 
technique, whether a diverting stoma was used, and  bowel preparation. 
Another study was done by Bruce et al
43
  who reviewed 49 studies 
concerning anastomotic leaks. These 49 studies to diagnose an 
anastomotic leak used 29 different definitions. One important factor in 
implicated increase in leaks is that they are at risk for loss of vascularity 
of the anorectal stump due to the removal of the distal mesorectum and 
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the subsequent low-level of many of these anastomosest.
44
  Low-lying 
anastomoses have been shown to be an independent risk factor for 
increased leakage risk by many studies
45,46,47
 . Eriksen
48
studied this issue 
from 1993 to 1998 in 1958 patients undergoing LAR with TME. He 
found the incidence was 11.6% and it was more in anastomoses that 
were less than six cm from anal verge, in patients undergoing 
neoadjuvant radiotherapy and in men. The authors concluded that 
protection by a diverting stoma was necessary after creating a low 
anastomoses with TME. 
However, the partial mesorectal excision (PME) which is a 
variation on TME mentioned by Law
37
 was developed to control leak 
rates by excising a good amount of mesorectum and not the entire 
mesorectum lying distal to the tumour. The name partial implied 
removal of healthy margin according to tumour location. Law and others 
used the technique on more proximal malignancies of the rectum and 
found decreased leak rates. Several studies
49
  have shown that the cancer 
spread distally for less than 3 cm. It is still not how much to leave behind 
distally, but for the malignancies that are more proximal; there has been 
a movement toward PME. One technical aspect is that of ‘coning’. 
Coning involves narrowing the circumferential margin of dissection 
producing a cone and not a cylinder of mesorectum, as it is performed 
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distally. If the surgeon “cones” the tissue, a lot of mesorectum will be 
left behind, and control of the cancer will be compromised. Further 
studies are required into PME. At present, PME is proven to lower leak 
rates statistically. A decrease in leak rate was also observed as the 
surgeon’s expertise with the technique increased. Carlsen's42  illustrated 
this point in a group of 76 patients who underwent TME. 
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PROBLEMS WITH FUNCTIONAL OUTCOME 
Increased incidence of urgency, fecal incontinence and bowel 
frequency is seen with TME.
50
 Certain factors affected the function of 
the bowel postoperatively. The factors which had an impact are   the 
level of the anastomoses, the type of anastomotic technique, the level of 
preoperative anorectal function, and whether they experienced an 
anastomotic leak. The factors which influenced due to surgical technique 
were sphincteric damage, a smaller rectal reservoir following 
proctectomy, and loss of pelvic nerves during sacral dissection leading to 
loss of sensation. Generally older patients were considered to have more 
functional problems and were a contra indication to low anterior 
resection, but it was not supported by a study done prospectively of 87 
patients underwent TME and an anastomsis within 1 cm of the sphincter 
. Follow-up was done for an average of 24.1 months, were grouped as 
younger (≤65 yrs) and older (>65 yrs). No significant difference was 
seen in between the younger and older patients in terms of urgency or 
the number of bowel movements per day or continence. In other studies 
as well, similar results have been replicated.
53
 
Kollmorgen and colleagues
54
 demonstrated postoperative 
deterioration of anorectal function from use of adjuvant radiotherapy. 
They compared 59 patients who didn’t receive radiation therapy and 41 
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patients who were subject to radiation post-operatively. Increased stool 
frequency per day were seen in the radiotherapy group (7).  The surgery 
alone group had less bowel movements (2).  More number of 
incontinence (17% versus 0) and more of clustered bowel movements 
(42 vs 3%) were also seen in the radiotherapy and surgery group. More 
common were also liquid bowel movements in the radiated patients. This 
led to more perianal skin problems (41 versus 12%). Hence wide 
difference was seen in the function of the bowel before and after 
treatment between the two groups (93 and 61%). 
Yamana et al
55
  suggested that we can predict postoperative 
outcome by the use of measuring preoperative anorectal function. 32 
patients who had a LAR were followed. Rectal sensory threshold, 
maximal tolerable rectal volume and anal mucosal electrosensitivity 
were decreased post-operatively. Yamana et al finally stated that patients 
who had a lower rectal sensory threshold, larger maximal tolerable rectal 
volume, and longer anal high-pressure zone had better postoperative anal 
function. 
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AUTONOMIC NERVE PRESERVATION AND IMPACT ON 
URINARY AND SEXUAL FUNCTION 
In the postoperative period with good control of disease, well-
preserved urologic and sexual function is possible. This is by the precise 
technique and sharp dissection of TME by sparing of the autonomic 
pelvic nerves during proctectomy. In contrast, the first descriptions of 
APR or LAR reports a male impotence rate nearing 100%.
56
 A 
retrospective study was conducted by Havenga et al
57
 on 129 patients 
who underwent a nerve-sparing TME based on a standardized 
questionnaire. Approximately 63% of female patients and 73% of male 
patients complained of no significant urinary symptoms after their 
procedure. The remainder complained of atleast 1 symptom such as 
incomplete bladder emptying, difficulty in bladder emptying, urinary 
leakage or dribbling or a feeling of urgency. Zero patients required long 
term catheterization. A higher incidence of these complaints was 
observed in those who received radiotherapy and underwent APR. 46% 
of older patients and 86% of patients under 60 yrs maintained normal 
sexual activity. Comparing LAR to APR, diminished sexual activity was 
not seen in 76% of LAR cases but only in 53% of APR patients. Erectile 
tumescence was seen in 67% of cases older than 60 and in 86% of cases 
under 60. Thirty three cases were younger who had LAR, and all of them 
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maintained spontaneous erection and their ability to engage in sexual 
intercourse. In about 40% of patients post-operatively, retrograde 
ejaculation was seen. Similarly good results were seen in female 
patients, with sexually activity maintained in 86% after surgery.  
Similar results were reported by Shirouzu at al
58
 .  Over 20-yrs, he 
made a review of 403 patients who had undergone proctectomy, Only a 
few  patients had a nerve-sparing dissection. The10-year disease-free 
survival rates and recurrence rates were neither increased nor decreased 
in the nerve preservation group, with only 2% lost to follow-up. In 
addition, in the nerve-sparing group, better preservation of urinary and 
sexual function was seen. In more than 80% of the nerve preserved 
patients, urinary function was preserved. In comparison, the other group 
had >90% of patients complaining of urinary disturbances. Likewise, 
65% of the nerve-preserved patients had preserved ejaculation and 79% 
could maintain erection.  
Kim and colleagues
59
 studied 68 men and assessed erectile 
dysfunction and prostate symptoms by performing urinary flowmetry 
and using questionnaires. All 68 men had undergone TME with nerve 
preservation for rectal malignancy. The function before and after surgery 
was compared. Preservation of nerves also preserved the ability to 
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maintain urinary flow, void volumes, orgasmic function, sexual desire, 
antegrade ejaculation and erection.  
 
 
 
NEOADJUVANT RADIOTHERAPY WITH TOTAL 
MESORECTAL EXCISION 
Neo-adjuvant radiation therapy with surgery produces lower rates 
of recurrence when compared to surgery alone. But most of these reports 
used a non standardized approach for surgery. Hence, a very high rate of 
recurrence was seen in the non adjuvant
60
 groups. The combination of 
Total Mesorectal Excision and pre-operative radiation therapy has 
lowered recurrence rates by at least 50%. Even with suboptimal 
resection, the use of both neoadjuvant chemo-radiotherapy and surgery 
improves survival. In the Swedish Rectal Cancer Trial,
61
 preoperative 
radiation therapy a shorter course  was given and local recurrence rates 
were reduced to 11% from 27%. It also increased 5-year survival to 58% 
from 48. But maximum benefit is seen when proper surgical technique is 
used with TME `and the survival benefit cannot be reproduced on any 
other setting. The Dutch Colorectal Cancer Group
38
  using only the 
principles of TME achieved an 8.2% local recurrence rate in the only 
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surgery group. Preoperative radiation of 25 Gy was used which further 
reduced the rate of local recurrence to 2.4%. However equivalent 2 years 
survival was noted in the two groups. Currently focus is on selecting 
those patients in whom neoadjuvant therapy would by most useful such 
as those with serosal disease so that cost and complications are reduced 
while maximizing oncological benefit. Magnetic Resonance Imaging is 
used successfully to find out the involvement of the circumferential 
radial margin. These patients would benefit from neoadjuvant 
therapy.
62,63,64
 
Another advantage of neoadjuvant radiation therapy is that the 
size of the tumor can be reduced and an APR can be avoided by 
increasing the distance from the sphincter and allowing sphincter-
preservation. A permanent colostomy may be avoided; however, caution 
must be used when changing the surgery based on tumor response. Even 
after a complete response to neoadjuvant treatment, microscopic nests of 
malignant cells seen in upto 75% of patients.
65
 Thus, the “melting” of the 
lesion does not change the true stage of the cancer. Keeping this in mind 
the surgeon must proceed with APR if the sphincter complex is 
involved.  
Use of Short-term neoadjuvant radiotherapy ( 25 Gy over 5 to 7 
days) had also led to increased sexual disturbance. It can also result in 
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decreased morbidity free life. Marijnen
66
and colleagues used the 
Rotterdam Symptom Checklist and studied the Quality of Life and 
sexual disturbance. A total of 990 patients who had undergone Total 
Mesorectal Excision were studied after randomization to  either only 
surgery or preoperative radiotherapy short term  (PRT). PRT negatively 
impacted  sexual function in both sexes. Daily activities were also 
statistically reduced in the PRT group. Defecation problems persisted in 
the PRT group. Both APR and LAR patients had similar results in the 
PRT group. Post APR patients scored better on their physical and 
psychological parameters. Worse urologic function however was seen in 
APR patients than those undergoing LAR. 
In the Dutch Colorectal Group
67
, late side effects from PRT were 
also analysed. There was a higher incidence of bowel dysfunction which 
persisted long term. Interestingly, neither stoma function nor urologic 
function or hospital treatment rates differ between the two groups. 
Patients in the radiotherapy arm also reported a higher rate of anal 
bleeding, mucous discharge and fecal incontinence. 
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THE NEED FOR A DIVERTING STOMA 
The complication of anastomtotic leak can be prevented by use of 
a diverting stoma. In which patients, a diverting stoma becomes 
applicable is less clear.  Obese individuals, anastomoses which are low, 
that is less than 6 cm from the anal verge, those under tension, male 
gender, donuts which are not complete, and advanced age have been 
cited as possible predictors of leaks. Koperna
74
  made a review of 70 
patients undergoing LAR and performed a cost-effectiveness analysis 
with a defunctioning stoma (n = 19) and without (n= 51) a defunctioning 
stoma. Significantly lower costs with avoidance of a stoma were seen 
when comparison was made with those with stoma. For LAR, 16.5% 
would have to be the leak rate of the anastomoses to balance the extra 
cost of a stoma. To limit the cost associated with a stoma, a goal of 
limiting the stoma rate to less than 10% of Low Anterior Resections was 
suggested. 
Dehni
75
  perfomed a study comparing leak rates in two sets of 
patients, those undergoing LCRA - low colorectal and those undergoing 
anal-pouch anastomoses. 258 consecutive patients in whom TME was 
performed were included in the study. A defunctioning stoma was placed 
in 30 of the 136 Low Colorectal Anastomoses patients and in all 122 
pouch patients. Clinically detected and radiologically detected leak rates 
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were tabulated. In Low Colorectal Anastomoses patients with a stoma, 
the leak was in only two patients of 30 patients, while in patients without 
a stoma, the clinical leak rate was 17%. However, the leak rate was only 
4.9 in patients with a pouch, which was not significantly different than 
the leak rate seen in those with a diversion in LCRA patients. Further 
advantages were seen in use of a stoma. It also decreased the clinical 
severity of leaks and the necessity for unscheduled surgeries to manage 
the leak. 
The Disability Adjusted Life Years were investigated in 24 
patients by O'Leary et al
76
  who underwent loop ileostomy and LAR for 
rectal malignancy and compared with 23 patients who underwent only 
Low Anterior Resection. Duration of stay in hospital, time to resume 
normal diet, and duration of time resume work was equivalent in both 
groups. However, physical conditioning scores showing a reduction at 
12 weeks was seen in the group with a stoma. This deficiency improved 
shortly after closure of the stoma. Time away from resuming work and 
length of stay in hospital were taken into consideration for ileostomy 
closure when compared with the non-diversion group. To limit some of 
these issues, appropriate but earlier closure of the stoma is advised. 
In summary, routine use of a stoma is unnecessary as the leak 
rates of experienced surgeons is less, and balancing the cost–benefit ratio 
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would make that uneconomical. If a stoma is required, additional costs 
can be limited by performing the closure at the earliest. It also helps 
return the patient to daily work. If within 6 cm of the anal verge lies the 
anastomosis, a loop ileostomy is preferable. It is also advisable in those 
patients in whom pre-operative chemo-radiotherapy has been used. 
Some centres suggest closure after a leak has been excluded with a 
water-soluble contrast study. The loop ileostomy is typically closed at 3 
months.  
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SUMMARY 
TME has now become the standard in surgical care to 
proctectomy for rectal malignancy. The local control of rectal cancer has 
been improved with TME by utilizing a meticulous and sharp dissection 
that removes all the lymphatic tissue and by staying within the natural 
fascial containment of the rectal tumor. As the experience of the surgeon 
increases, blood loss, anastomotic leaks and other complications are 
limited. Complimentary in minimizing local and distant recurrence is use 
of neo-adjuvant therapy.  
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MATERIALS AND METHODS 
   Data on 50 patients with mid and low rectal malignancy planned 
for resectional surgery in the departments of General Surgery and 
Surgical Gastro-enterology from May 2011 to October 2013 were 
entered onto a database.  
 The Patient related factors such as age of the patient , the sex of 
the patient,  Body mass index  of the patient, the Disease related factors 
such as the distance of the tumor in cm from the anal verge as measured 
by colonoscopy, pT category determined after pathological examination 
and finally Surgery related factors such as  duration of the surgery in 
mins, the use of neo-adjuvant therapy in the form of chemo-radiotherapy 
, surgical approach – laparoscopic/ open method, use of mono-polar 
diathermy or blunt dissection or other methods of dissection such as 
bipolar coagulation, harmonic device, ultrasonic dissector and presence 
of intra-operative complications such as pelvic haemorrhage or 
perforation were analysed as clinically affecting variables .  
 Pathology reports of those patients who underwent total 
mesorectal excision were examined and the TME scores added to the 
database. Continuous variables were analysed using ANOVA, 
Categorical variables were analysed using the χ2 test. P < 0.05 was taken 
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as statistically significant. Calculations were done using SPSS 2.0 
software.  
 TME quality data was assessed by the operating surgeon and the 
pathologist and recorded into a two tier grading system: complete TME 
was classified as ‘optimal’, while nearly complete and incomplete TME 
were classified as ‘sub-optimal’.  
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INCLUSION CRITERIA 
 All patients with Rectal Adenocarcinoma of the middle and lower 
thirds who underwent Low Anterior resection or Abdomino-perineal 
resection with the following criteria were included in the study: 
-Histology proven by pre-operative colonoscopy 
-Staging workup including CT abdomen and chest which revealed no 
distant metastases 
-Diagnostic Laparoscopy which showed no peritoneal seeding or ascitis 
or unresectable disease. 
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EXCLUSION CRITERIA 
 Exclusion criteria were patients who had  
- Procto-colectomy or  
-Hartmann’s Procedure or, 
-Local Tumor Excision  
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Figure 1: anterior dissection between rectum and bladder by incising 
rectovesical fascia 
 
 
Figure 2: posterior dissection between rectum and presacral fascia 
preserving autonomic nerves and presacral vessels 
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Figure 3: Posterior surface smooth, no defects in mesorectal fascia, no 
incisions or tearing, baby bottom appearance 
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Figure 4: Perineal phase of surgery after inserting purse-string suture 
 
 
 
Figure 5: Abdominal phase completed with bipolar sharp dissection - 
no residual mesorectal tissue, secured hemostasis. Peritoneum closed. 
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Figure 6:‘Complete TME’ : Mesorectum intact and smooth, defects not 
deeper than 5 mm , no coning, CRM is smooth and regular 
 
 
 
 
 
Figure 7: ‘Incomplete TME’ - mesorectum shows little bulk, defects 
beyond muscularis propria, marked coning and CRM irregularity 
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OBSERVATIONS AND RESULTS 
 
 Between May 2011 and October 2013, 50 patients who had a total 
mesorectal excision for adenocarcinoma of mid or lower third of the 
rectum were enrolled in the study. All resected specimens were scored as 
per specimen grading criteria as followed in PROCARE study.  
 
 TME scores were TME1 n = 38, TME2 n = 8, TME3 n =4. 
 
16 patients underwent anterior resection and 34 underwent 
abdomino-perineal resection. Of the patients who underwent LAR, 4 
patients had sub-optimal TME(25%) 
TME QUALITY 
TME 1 
TME 2 
TME 3 
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, 
while of the patients who underwent APR, 8 patients(23.5%)  had sub-
optimal TME. 
 
Relation of Age with TME status: 
The median age of the patients was 60 years (range 54–70  years) 
with 14 patients less than 55 yrs and 2 patients(14.3%) with sub-optimal 
TME, 27 patients between 55 and 75 years and 7 patients(25.9%) 
Surgery 
OPTIMAL LAR 
OPTIMAL APR 
SUB-OPTIMAL LAR 
SUB-OPTIMAL APR 
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AGE Optimal Sub-optimal Total
<55 12 2 14
55-75 20 7 27
>75 6 3 9  
 
with sub-optimal TME and 9 patients over 75 years with 3 patients 
(33.3%) with sub-optimal TME . 
 
Relation of Sex with TME Status: 
Twenty three patients were male with 7 patients (30.5%)  
having  sub - optimal  TME,   while   27   patients   were 
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female with 5 patients (18.5%) having sub-optimal TME 
Sex Optimal Sub-optimal Total
Male 16 7 23
Female 22 5 27
 
 
 The mean BMI was 20.46 kg/m2 with a range of 7 (17-24 kg/m2).  
 Twenty-one patients had a BMI less than 20 kg/m2 with 5 patients 
(23.8%) having sub-optimal TME, while 9 patients had a BMI between 
20  to  25  kg/m2  with  7  patients (24.1%)  having sub-optimal TME. 
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BMI Optimal Sub-optimal Total
<20 16 5 21
20-30 22 7 29
 
 
Relation of duration of Surgery with TME status: 
 
The mean duration of surgery was 200.3 mins with  
6 patients having duration less than 150 mins and 1 patient (16.7%)   
with sub-optimal TME, 26 patients with duration between 150 to  
240  mins  with  sub - optimal  TME  in  5  patients  (19.2%), 
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and 18 patients with surgery lasting more than 240 mins with sub-
optimal TME in 6 patients (33.3%). 
Duration of Surgery Optimal Sub-optimal Total
<150 5 1 6
150-240 21 5 26
>240 12 6 18
 
 
Relation of distance from anal verge with TME : 
 
Thirty-four patients were found to have tumour within 8 cm  
of  the  anal  verge,  with  sub-optimal  TME  in  9  patients(26.4%),  
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and 16 patients had tumour more than 8 cm from the anal verge 
with 3 patients (18.7%)having sub-optimal TME.   
Distance from anal verge Optimal Sub-optimal Total
<8cm 25 13 38
>8cm 9 3 12
 
 
Relation of Neo-adjuvant therapy with TME : 
 
Thirty-eight patients were treated with preoperative chemo-
radiotherapy of which 10 patients (26.3%) had sub-optimal TME, while  
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Neo-adjuvant therapy Optimal Sub-optimal Total
None 10 2 12
CTRT 28 10 38
 
 
12 patients did not  require neo-adjuvant therapy, in which  
2  patients  (22.2%)  had  sub-optimal  TME. 
 
Relation of dissection method with TME: 
 
Monopolar diathermy was used as the primary dissecting modality 
in 31 patients with 9 patients (26.3%) showing sub-optimal TME, while  
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19 patients  had other forms of dissection (bipolar diathermy, harmonic 
scalpel)  with  3  patients (15.8%)  having  sub-optimal  TME . 
Method of dissection Optimal Sub-optimal Total
Monopolar/ Blunt 22 9 31
Other methods 16 3 19
 
 
Relation of Intra-op complications with TME: 
 
Intra-operative complications were seen in 11 patients with 7 
patients (63.7%) having sub-optimal TME, While no complications  
were  seen  in  39  patients   with  sub-optimal  TME  in  5  of  them. 
0 
5 
10 
15 
20 
25 
Monopolar/ Blunt Other methods 
N
im
b
e
r 
TME 
Optimal 
Sub-optimal 
86 
 
 
 
Complications Optimal Sub-optimal Total
No Complications 34 5 39
Complications 4 7 11
 
 
Relation of PT Category with TME: 
 
Pathological examination of the specimen for pT stage showed 8 
patients had a category pt1/2 with 1 patient(12.5%) having sub- 
optimal  TME,   20  patients  had  a  pT3  with  3  patients  (15%) 
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having sub-optimal TME, and 22 patients fell into pT4 with 8 
patients(36.3%)  having sub-optimal TME. 
pT Stage Optimal Sub-optimal Total 
pT1/2 7 1 8 
pT3 17 3 20 
pT4 14 8 22 
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Relation of surgical approach with TME: 
 
. Laparoscopic approach was used in 12 patients with 1 patient 
(8.3%) having sub-optimal TME, while Open approach was followed in 
38 patients with 11 patients (28.9%) having sub-optimal TME.   
 
 
 
Surgical method Optimal Sub-optimal Total
Open 27 11 38
Lap 11 1 12
 
 
 
0 
5 
10 
15 
20 
25 
30 
35 
40 
Open Lap 
Sub-optimal 
Optimal 
89 
 
CONCLUSION AND RECOMMENDATIONS 
 Pathological tumour category T4 was more significantly 
associated (p<0.05) with sub-optimal TME than T3 or T1/2 tumours 
which was due to proximity of CRM to the tumor. Also significant 
(p<0.05) were presence of intra-operative complications and surgery 
lasting longer than 240 mins. Use of monopolar or blunt dissection was 
also independently associated with moderate or poor TME quality 
(p<0.05).  
 Total mesorectal excision scores were not statistically influenced 
by gender of patients (p=0.213), both male and female patients 
producing comparable TME. Though male pelvis being narrower was 
suggested in previous studies to result in a poorer TME, no difference 
was seen in this study. 
 Age of the patients (p=0.288) also did not affect TME with 
patients across all age groups producing no difference statistically. TME 
also did not vary with BMI (p=0.973) but this was not significant as all 
patients fell within a narrow BMI range in this study. 
 The distance of tumour from anal verge (p=0.578) did not affect 
TME, be it mid or a low rectal tumour, although previous studies 
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demonstrated a poorer TME with low rectal tumours due to coning, but 
this was not seen in our study. 
 The type of surgical approach (p=0.72) or preoperative chemo-
radiotherapy (p=0.376) also did not affect TME with equivalent results 
in both groups. This can be explained due to decrease in size of the 
tumor with neoadjuvant chemoradiotherapy which provided an adequate 
CRM.  
 Hence, more care and meticulous dissection is advisable in locally 
advanced T4 lesions to ensure adequate CRM. Also, an inadequate TME 
can be anticipated in those surgeries where complications are 
encountered as a result of which duration progresses beyond 4 hours. 
Since these variables are more difficult to control, the variable which can 
be controlled is alteration of dissection from monopolar or blunt 
dissection to bipolar or harmonic dissection.  
 Overall, though many variables are found to influence TME in 
resected specimens, the expertise of the surgeon is also a factor. Control 
of all these factors helps in providing optimal TME, which promises the 
lowest local and distant recurrence in surgery for rectal cancer at this 
time. 
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ANNEXURES 
AJCC TNM Staging System for Colorectal Cancer 
Primary Tumor (T) 
TX Primary tumor cannot be assessed 
T0 No evidence of primary tumor 
Tis Carcinoma in situ: intraepithelial  
T1 Tumor invades submucosa 
T2 Tumor invades muscularis propria 
T3 Tumor invades through the muscularis propria into the 
subserosa, or into nonperitonealized pericolic or perirectal 
tissues 
T4 Tumor directly invades other organs or structures and/or 
perforates visceral peritoneum 
Regional Lymph Nodes (N) 
NX Regional lymph nodes cannot be assessed 
N0 No regional lymph node metastasis 
N1 Metastasis in 1 to 3 regional lymph nodes 
N2 Metastasis in 4 or more regional lymph nodes 
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Distant Metastasis (M) 
MX Distant metastasis cannot be assessed 
M0 No distant metastasis 
M1 Distant metastasis 
Stage Grouping 
STAGE T N M DUKES MAC 
0 Tis N0 M0     
I T1 N0 M0 A A 
  T2 N0 M0 A B1 
IIA T3 N0 M0 B B2 
IIB T4 N0 M0 B B3 
IIIA T1-T2 N1 M0 C C1 
IIIB T3-T4 N1 M0 C C2/C3 
IIIC Any T N2 M0 C C1/C2/C3 
IV Any T Any N M1   D 
 
  
104 
 
PATHOLOGICAL GRADING OF TME 
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PROFORMA  
 
• NAME :          SL. NO: 
• AGE /SEX:  
• ADDRESS WITH CONTACT NUMBER:  
• IP NO:  
• DATE OF ADMISSION:  
• DATE OF SURGERY:  
• DATE OF DISCHARGE:  
HISTORY OF PRESENTING ILLNESS:  
• MASS PER RECTUM:  
• Onset-  
• Duration-   
• Progress-  
• Persistent or intermittent- 
 
• PAIN:  
• Site-  
• Duration-  
• Nature-  
• Aggravating/relieving factors-  
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• DISCHARGE FROM THE ANUS, IF ANY: 
• BLEEDING PER RECTUM, IF ANY: 
• PAIN ABDOMEN 
• CONSTIPATION/ DIARRHOEA 
 
 
PAST HISTORY:  
   WHETHER A KNOWN CASE OF 
DM/HYPERTENSION/ASTHMA/TB/EPILEPSY/CARDIAC 
ILLNESS  
H/O SIMILAR EPISODES IN THE PAST, IF ANY: 
H/O ANAL/RECTAL SURGERIES IN THE PAST, IF ANY: 
H/O TRAUMA TO PERINEAL REGION IN THE PAST, IF ANY 
H/O MAJOR ILLNESS/ HOSPITAL ADMISSIONS, IF ANY 
 
PERSONAL HISTORY: 
WHETHER HE WAS A SMOKER OR AN ALCOHOLIC 
FAMILY HISTORY: 
DIETARY HISTORY: 
TREATMENT HISTORY: 
 USE OF NEO-ADJUVANT CHEMOTHERAPY 
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CLINICAL EXAMINATION:  
GENERAL EXAMINATION: 
 VITALS: 
 BMI: 
SYSTEMIC EXAMINATION: 
CVS 
RS 
PER ABDOMEN 
CNS 
LOCAL EXAMINATION: 
• PR: 
• PROCTOSCOPY: 
 
CLINICAL DIAGNOSIS: 
 
INVESTIGATIONS:  
• SIGMOIDOSCOPY: 
• COLONOSCOPY 
•  CECT ABDOMEN & PELVIS:  
• ROUTINE INVESTIGATIONS(CBC,RFT,CXR,ECG) 
• OTHER INVESTIGATIONS(IF ANY): 
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FINAL DIAGNOSIS:  
 
SURGERY DONE: 
  TYPE OF SURGERY: 
 SURGICAL APPROACH: 
 DURATION OF SURGERY: 
 TUMOUR DISTANCE FROM ANAL VERGE: 
TECHNIQUES OF PELVIC DISSECTION: 
(BLUNT DISSECTION/ MONOPOLAR COAGULATION    VS  
OTHER TECHNIQUES – BIPOLAR COAGULATION, HARMONIC 
DEVICE, WATERJET DISSECTION DEVICE, ULTRASOUND 
DISSECTOR, BIPOLAR VESSEL SEALER DEVICE) 
PRESENCE OF INTRA-OPERATIVE COMPLICATIONS: 
POST OPERATIVE COMPLICATIONS, IF ANY: 
HPE: 
PT-  PATHOLOGICAL TUMOUR STAGING ( pT1/T2, pT3, pT4) 
TME OPTIMAL  vs TME SUBOPTIMAL 
FOLLOW UP: 
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